Meteora Capital’s Zura Bio Limited Warrants ZURAW Stock Holding History

Meteora Capital’s Portfolio ZURAW Stock Details ZURAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-527,362	Closed	-$211K	–	271
2024 Q2	$211K	Buy	527,362 +430,131	+442%	+$218K	0.04%	148
2024 Q1	$26.3K	Sell	97,231 -33,055	-25%	-$9.74K	﹤0.01%	181
2023 Q4	$21.8K	Buy	130,286 +70,309	+117%	+$30.4K	﹤0.01%	215
2023 Q3	$19.6K	Sell	59,977 -2	-0%	-$1	﹤0.01%	238
2023 Q2	$21K	Sell	59,979 -179,824	-75%	-$63.4K	﹤0.01%	236
2023 Q1	$62.3K	Sell	239,803 -30,116	-11%	-$8.6K	0.01%	257
2022 Q4	$40.5K	Buy	269,919 +96,600	+56%	+$9.45K	0.01%	208
2022 Q3	$28K	Buy	173,319 +5,800	+3%	+$1.07K	0.01%	237
2022 Q2	$30K	Buy	+167,519	New	+$45.4K	0.01%	322

Meteora Capital's ZURAW Position: Q3 2024 in Review

Meteora Capital sold out of Zura Bio Limited Warrants (ZURAW) in Q3 2024, closing a stake of 527,362 shares — an estimated $211K sold.

Meteora Capital first reported a position in ZURAW in Q2 2022 and held it in 9 quarters. The position peaked at $211K in Q2 2024. 0 funds tracked by Wall St. Rank hold ZURAW as of Q3 2024.

Meteora Capital reported no remaining Zura Bio Limited Warrants position as of Q3 2024 after selling out during the quarter.
Meteora Capital sold 527,362 Zura Bio Limited Warrants shares in Q3 2024, an estimated $211K.
Meteora Capital first reported a position in Zura Bio Limited Warrants in Q2 2022 and held it in 9 quarters.
Meteora Capital's Zura Bio Limited Warrants position peaked at $211K in Q2 2024.
0 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q3 2024.

Based on Meteora Capital's 13F filing for Q3 2024, filed 14 Nov 2024.